Report cover image

Immune Repertoire Sequencing Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Assay Kits & Reagents), By Type, By Application (Oncology & Cancer Immunotherapy, Transplantation & Immune Tolerance), By End-use (Academic & Resea

Publisher Grand View Research
Published Nov 21, 2025
Length 120 Pages
SKU # GV20649659

Description

Immune Repertoire Sequencing Market Summary

The global immune repertoire sequencing market size was estimated at USD 328.2 million in 2024 and is projected to reach USD 894.2 million by 2033, growing at a CAGR of 11.89% from 2025 to 2033. The increasing adoption of next-generation sequencing technologies, applications in immunotherapy and vaccine development, and investments in precision medicine research drive the market growth.

Global Immune Repertoire Sequencing Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global immune repertoire sequencing market report based on product & service, type, application, end-use, and region:
  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Assay Kits & Reagents
  • TCR kits
  • BCR kits
  • Others
  • Services
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bulk immune repertoire sequencing
  • Single cell immune repertoire sequencing
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology & Cancer Immunotherapy
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases & Vaccine Development
  • Transplantation & Immune Tolerance
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Product & Service Segment
1.2.2. Type Segment
1.2.3. Application Segment
1.2.4. End use Segment
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Immune Repertoire Sequencing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing adoption of personalized medicine
3.2.1.2. Rising prevalence of immune-related diseases
3.2.1.3. Advancements in high-throughput sequencing technologies
3.2.2. Market restraint analysis
3.2.2.1. High cost of sequencing technologies
3.2.2.2. Complex data analysis and interpretation
3.3. Immune Repertoire Sequencing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Immune Repertoire Sequencing Market: Product & Service Estimates & Trend Analysis
4.1. Product & Service Segment Dashboard
4.2. Global Immune Repertoire Sequencing Market Product & Service Movement Analysis
4.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Assay Kits & Reagents
4.5.1. Assay Kits & Reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5.2. TCR kits
4.5.2.1. TCR kits market estimates and forecasts 2021 to 2033 (USD Million)
4.5.3. BCR kits
4.5.3.1. BCR kits market estimates and forecasts 2021 to 2033 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Immune Repertoire Sequencing Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Global Immune Repertoire Sequencing Market Type Movement Analysis
5.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
5.4. Bulk immune‑repertoire sequencing
5.4.1. Bulk immune‑repertoire sequencing market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Single‑cell immune‑repertoire sequencing
5.5.1. Single‑cell immune‑repertoire sequencing market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Immune Repertoire Sequencing Market: Application Estimates & Trend Analysis
6.1. Application Segment Dashboard
6.2. Global Immune Repertoire Sequencing Market Application Movement Analysis
6.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Oncology & Cancer Immunotherapy
6.4.1. Oncology & Cancer Immunotherapy market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Autoimmune & Inflammatory Diseases
6.5.1. Autoimmune & Inflammatory Diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Infectious Diseases & Vaccine Development
6.6.1. Infectious Diseases & Vaccine Development market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Transplantation & Immune Tolerance
6.7.1. Transplantation & Immune Tolerance market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Immune Repertoire Sequencing Market: End Use Estimates & Trend Analysis
7.1. End Use Segment Dashboard
7.2. Global Immune Repertoire Sequencing Market End Use Movement Analysis
7.3. Global Immune Repertoire Sequencing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Academic & Research Institutes
7.4.1. Academic & Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Pharmaceutical & Biotechnology Companies
7.5.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Others
7.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Immune Repertoire Sequencing Market: Regional Estimates & Trend Analysis by Product & Service, Type, Application, and End Use
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
8.4.2. U.S.
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
8.4.3. Canada
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
8.4.4. Mexico
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework
8.4.4.3. Competitive scenario
8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
8.5.2. UK
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
8.5.3. Germany
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
8.5.4. France
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
8.5.5. Italy
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
8.5.6. Spain
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
8.5.7. Norway
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
8.5.8. Sweden
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
8.5.9. Denmark
8.5.9.1. Key country dynamics
8.5.9.2. Regulatory framework
8.5.9.3. Competitive scenario
8.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
8.6.2. Japan
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
8.6.3. China
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
8.6.4. India
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
8.6.5. Australia
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
8.6.6. South Korea
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
8.6.7. Thailand
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework
8.6.7.3. Competitive scenario
8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
8.7.2. Brazil
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
8.7.3. Argentina
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework
8.7.3.3. Competitive scenario
8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
8.8.2. South Africa
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
8.8.4. UAE
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key country dynamics
8.8.5.2. Regulatory framework
8.8.5.3. Competitive scenario
8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. QIAGEN
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. New England Biolabs
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Takara Bio
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Illumina, Inc.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. iRepertoire
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. BGI
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Danaher
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Creative Biolabs
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Nucleus Biotech
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. Celemics, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us